Sutro Biopharma
Sutro Biopharma is seeking a Controller to lead accounting operations, financial close, and internal controls for a public, pre-commercial biotechnology company. This hands-on leadership role involves ensuring reliable financial information, managing a high-performing team, and improving processes within a lean organization. The position requires partnering across Finance and business units to balance public-company rigor with practical execution.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2003
Sutro Biopharma is a clinical-stage biotechnology company based in South San Francisco that discovers, develops, and manufactures protein therapeutics for cancer and autoimmune diseases. It leverages an integrated cell-free protein synthesis platform, XpressCF, to design and produce modalities including cytokine-based immuno-oncology agents, bispecific antibodies, and antibody–drug conjugates (ADCs). Its lead ADC candidates, STRO-001 (anti‑CD74 for multiple myeloma and non‑Hodgkin lymphoma) and STRO-002 (anti‑folate receptor‑α for ovarian and endometrial cancers), are engineered with site-specific linker–warhead placement to optimize therapeutic index. Sutro focuses on directing potent modalities at clinically validated targets to accelerate translation from discovery through manufacturing.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sutro Biopharma.
128% above the average for this role